![1OL 1OL](https://data.pdbj.org/pdbjplus/data/cc/svg/1OL.svg) | 1OL | Name: | (2R,4S,5S)-5-amino-4-hydroxy-2,7-dimethyloctanoic acid | Formula: | C10 H21 N O3 | SMILES: | O=C(O)C(C)CC(O)C(N)CC(C)C | InChi: | InChI=1S/C10H21NO3/c1-6(2)4-8(11)9(12)5-7(3)10(13)14/h6-9,12H,4-5,11H2,1-3H3,(H,13,14)/t7-,8+,9+/m1/s1 | Synonyms: | Leu*Ala | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | (2R,4S,5S)-5-amino-4-hydroxy-2,7-dimethyloctanoic acid |
|
![1OP 1OP](https://data.pdbj.org/pdbjplus/data/cc/svg/1OP.svg) | 1OP | Name: | O-(5-hydroxypentyl)-L-tyrosine | Formula: | C14 H21 N O4 | SMILES: | O=C(O)C(N)Cc1ccc(OCCCCCO)cc1 | InChi: | InChI=1S/C14H21NO4/c15-13(14(17)18)10-11-4-6-12(7-5-11)19-9-3-1-2-8-16/h4-7,13,16H,1-3,8-10,15H2,(H,17,18)/t13-/m0/s1 | Definition date: | 2013-04-11 | Last modified: | 2023-11-03 | Release date: | 2013-06-12 | Identifier: | O-(5-hydroxypentyl)-L-tyrosine |
|
![LQU LQU](https://data.pdbj.org/pdbjplus/data/cc/svg/LQU.svg) | LQU | Name: | 3-[(4R)-2-acetyl-1,2,3,4-tetrahydroisoquinolin-4-yl]benzonitrile | Formula: | C18 H16 N2 O | SMILES: | N#Cc1cccc(c1)C1CN(Cc2ccccc21)C(C)=O | InChi: | InChI=1S/C18H16N2O/c1-13(21)20-11-16-6-2-3-8-17(16)18(12-20)15-7-4-5-14(9-15)10-19/h2-9,18H,11-12H2,1H3/t18-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 3-[(4R)-2-acetyl-1,2,3,4-tetrahydroisoquinolin-4-yl]benzonitrile |
|
![LR0 LR0](https://data.pdbj.org/pdbjplus/data/cc/svg/LR0.svg) | LR0 | Name: | (7R)-N-(4-acetamidopyridin-3-yl)-4-fluorobicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide | Formula: | C16 H14 F N3 O2 | SMILES: | O=C(Nc1cnccc1NC(C)=O)C1Cc2ccc(F)cc21 | InChi: | InChI=1S/C16H14FN3O2/c1-9(21)19-14-4-5-18-8-15(14)20-16(22)13-6-10-2-3-11(17)7-12(10)13/h2-5,7-8,13H,6H2,1H3,(H,20,22)(H,18,19,21)/t13-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (7R)-N-(4-acetamidopyridin-3-yl)-4-fluorobicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide |
|
![1PA 1PA](https://data.pdbj.org/pdbjplus/data/cc/svg/1PA.svg) | 1PA | Name: | 4-(carboxymethyl)-L-phenylalanine | Formula: | C11 H13 N O4 | SMILES: | O=C(O)C(N)Cc1ccc(cc1)CC(=O)O | InChi: | InChI=1S/C11H13NO4/c12-9(11(15)16)5-7-1-3-8(4-2-7)6-10(13)14/h1-4,9H,5-6,12H2,(H,13,14)(H,15,16)/t9-/m0/s1 | Synonyms: | p-(carboxymethyl)phenylalanine | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | 4-(carboxymethyl)-L-phenylalanine |
|
![LRC LRC](https://data.pdbj.org/pdbjplus/data/cc/svg/LRC.svg) | LRC | Name: | 2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C13 H12 Cl N3 O | SMILES: | O=C(Nc1cnccc1C)Cc1cc(Cl)cnc1 | InChi: | InChI=1S/C13H12ClN3O/c1-9-2-3-15-8-12(9)17-13(18)5-10-4-11(14)7-16-6-10/h2-4,6-8H,5H2,1H3,(H,17,18) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide |
|
![LRN LRN](https://data.pdbj.org/pdbjplus/data/cc/svg/LRN.svg) | LRN | Name: | 1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one | Formula: | C20 H36 N2 O2 | SMILES: | O=C(C)N1CCCC(C1)N(CC1CCCCC1)C1CCC(O)CC1 | InChi: | InChI=1S/C20H36N2O2/c1-16(23)21-13-5-8-19(15-21)22(14-17-6-3-2-4-7-17)18-9-11-20(24)12-10-18/h17-20,24H,2-15H2,1H3/t18-,19-,20-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one |
|
![LS0 LS0](https://data.pdbj.org/pdbjplus/data/cc/svg/LS0.svg) | LS0 | Name: | 2-(6-fluoro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C16 H14 F N3 O | SMILES: | Cc1ccncc1NC(=O)Cn1ccc2ccc(F)cc21 | InChi: | InChI=1S/C16H14FN3O/c1-11-4-6-18-9-14(11)19-16(21)10-20-7-5-12-2-3-13(17)8-15(12)20/h2-9H,10H2,1H3,(H,19,21) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(6-fluoro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide |
|
![LSF LSF](https://data.pdbj.org/pdbjplus/data/cc/svg/LSF.svg) | LSF | Name: | N-(4-methylpyridin-3-yl)-2-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)acetamide | Formula: | C17 H17 N3 O3 | SMILES: | Cc1ccncc1NC(=O)Cc1cccc(OC2CC(=O)N2)c1 | InChi: | InChI=1S/C17H17N3O3/c1-11-5-6-18-10-14(11)19-15(21)8-12-3-2-4-13(7-12)23-17-9-16(22)20-17/h2-7,10,17H,8-9H2,1H3,(H,19,21)(H,20,22)/t17-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(4-methylpyridin-3-yl)-2-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)acetamide |
|
![1QI 1QI](https://data.pdbj.org/pdbjplus/data/cc/svg/1QI.svg) | 1QI | Name: | (2R,4S,5S)-5-azanyl-6-methyl-4-oxidanyl-2-(phenylmethyl)heptanoic acid | Formula: | C15 H23 N O3 | SMILES: | CC(C)[CH](N)[CH](O)C[CH](Cc1ccccc1)C(O)=O | InChi: | InChI=1S/C15H23NO3/c1-10(2)14(16)13(17)9-12(15(18)19)8-11-6-4-3-5-7-11/h3-7,10,12-14,17H,8-9,16H2,1-2H3,(H,18,19)/t12-,13+,14+/m1/s1 | Definition date: | 2021-06-14 | Last modified: | 2023-11-03 | Release date: | 2021-08-11 | Identifier: | (2~{R},4~{S},5~{S})-5-azanyl-6-methyl-4-oxidanyl-2-(phenylmethyl)heptanoic acid |
|
![LSO LSO](https://data.pdbj.org/pdbjplus/data/cc/svg/LSO.svg) | LSO | Name: | (Z)-N~6~-(3-CARBOXY-1-{[(4-CARBOXY-2-OXOBUTYL)SULFONYL]METHYL}PROPYLIDENE)-L-LYSINE | Formula: | C16 H26 N2 O9 S | SMILES: | O=S(=O)(C/C(=N/CCCCC(C(=O)O)N)CCC(=O)O)CC(=O)CCC(=O)O | InChi: | InChI=1S/C16H26N2O9S/c17-13(16(24)25)3-1-2-8-18-11(4-6-14(20)21)9-28(26,27)10-12(19)5-7-15(22)23/h13H,1-10,17H2,(H,20,21)(H,22,23)(H,24,25)/b18-11+/t13-/m0/s1 | Synonyms: | 2-AMINO-6-[3-CARBOXY-2-OXO-BUTANE-1-SULFONYLMETHYL-PROPYLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2023-11-03 | Identifier: | (E)-N~6~-(3-carboxy-1-{[(4-carboxy-2-oxobutyl)sulfonyl]methyl}propylidene)-L-lysine |
|
![LT9 LT9](https://data.pdbj.org/pdbjplus/data/cc/svg/LT9.svg) | LT9 | Name: | 1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)-3-oxocyclobutane-1-carboxamide | Formula: | C17 H15 Cl N2 O2 | SMILES: | O=C(Nc1cnccc1C)C1(CC(=O)C1)c1cccc(Cl)c1 | InChi: | InChI=1S/C17H15ClN2O2/c1-11-5-6-19-10-15(11)20-16(22)17(8-14(21)9-17)12-3-2-4-13(18)7-12/h2-7,10H,8-9H2,1H3,(H,20,22) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)-3-oxocyclobutane-1-carboxamide |
|
![LTA LTA](https://data.pdbj.org/pdbjplus/data/cc/svg/LTA.svg) | LTA | Name: | 4,8-DIAMINO-3-HYDROXY-OCTANOIC ACID ETHYL ESTER | Formula: | C10 H22 N2 O3 | SMILES: | O=C(OCC)CC(O)C(N)CCCCN | InChi: | InChI=1S/C10H22N2O3/c1-2-15-10(14)7-9(13)8(12)5-3-4-6-11/h8-9,13H,2-7,11-12H2,1H3/t8-,9-/m0/s1 | Synonyms: | STATINE ANALOGUE | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | ethyl (3S,4S)-4,8-diamino-3-hydroxyoctanoate |
|
![1JM 1JM](https://data.pdbj.org/pdbjplus/data/cc/svg/1JM.svg) | 1JM | Name: | 4-carboxy-N-methyl-D-phenylalanine | Formula: | C11 H13 N O4 | SMILES: | O=C(O)C(NC)Cc1ccc(cc1)C(=O)O | InChi: | InChI=1S/C11H13NO4/c1-12-9(11(15)16)6-7-2-4-8(5-3-7)10(13)14/h2-5,9,12H,6H2,1H3,(H,13,14)(H,15,16)/t9-/m1/s1 | Definition date: | 2013-02-15 | Last modified: | 2023-11-03 | Release date: | 2013-11-06 | Identifier: | 4-carboxy-N-methyl-D-phenylalanine |
|
![LTU LTU](https://data.pdbj.org/pdbjplus/data/cc/svg/LTU.svg) | LTU | Name: | 2-Amino-3-hydroxy-3-[1-[2-(oxiran-2-yl)propan-2-yl]indol-3-yl]propanoic acid | Formula: | C16 H20 N2 O4 | SMILES: | CC(C)([CH]1CO1)n2cc([CH](O)[CH](N)C(O)=O)c3ccccc23 | InChi: | InChI=1S/C16H20N2O4/c1-16(2,12-8-22-12)18-7-10(14(19)13(17)15(20)21)9-5-3-4-6-11(9)18/h3-7,12-14,19H,8,17H2,1-2H3,(H,20,21)/t12-,13+,14-/m1/s1 | Synonyms: | (2~{S},3~{R})-2-azanyl-3-oxidanyl-3-[1-[2-[(2~{S})-oxiran-2-yl]propan-2-yl]indol-3-yl]propanoic acid | Definition date: | 2022-07-12 | Last modified: | 2023-11-03 | Release date: | 2023-03-29 | Identifier: | (2~{S},3~{R})-2-azanyl-3-oxidanyl-3-[1-[2-[(2~{S})-oxiran-2-yl]propan-2-yl]indol-3-yl]propanoic acid |
|
![LUC LUC](https://data.pdbj.org/pdbjplus/data/cc/svg/LUC.svg) | LUC | Name: | 2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C17 H16 Cl N3 O3 | SMILES: | Cc1ccncc1NC(=O)Cc1cc(Cl)cc(OC2CC(=O)N2)c1 | InChi: | InChI=1S/C17H16ClN3O3/c1-10-2-3-19-9-14(10)20-15(22)6-11-4-12(18)7-13(5-11)24-17-8-16(23)21-17/h2-5,7,9,17H,6,8H2,1H3,(H,20,22)(H,21,23)/t17-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
![LV9 LV9](https://data.pdbj.org/pdbjplus/data/cc/svg/LV9.svg) | LV9 | Name: | N-(4-benzyloxan-4-yl)-N'-(pyridin-3-yl)urea | Formula: | C18 H21 N3 O2 | SMILES: | O=C(NC1(CCOCC1)Cc1ccccc1)Nc1cccnc1 | InChi: | InChI=1S/C18H21N3O2/c22-17(20-16-7-4-10-19-14-16)21-18(8-11-23-12-9-18)13-15-5-2-1-3-6-15/h1-7,10,14H,8-9,11-13H2,(H2,20,21,22) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(4-benzyloxan-4-yl)-N'-(pyridin-3-yl)urea |
|
![LVM LVM](https://data.pdbj.org/pdbjplus/data/cc/svg/LVM.svg) | LVM | Name: | N-(4-methylpyridin-3-yl)-2-(spiro[2.3]hexan-5-yl)acetamide | Formula: | C14 H18 N2 O | SMILES: | O=C(Nc1cnccc1C)CC1CC2(CC2)C1 | InChi: | InChI=1S/C14H18N2O/c1-10-2-5-15-9-12(10)16-13(17)6-11-7-14(8-11)3-4-14/h2,5,9,11H,3-4,6-8H2,1H3,(H,16,17) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(4-methylpyridin-3-yl)-2-(spiro[2.3]hexan-5-yl)acetamide |
|
![1TQ 1TQ](https://data.pdbj.org/pdbjplus/data/cc/svg/1TQ.svg) | 1TQ | Name: | 6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN | Formula: | C12 H13 N3 O4 | SMILES: | O=C(O)C(N)Cc2c1ccc(c(O)c1nc2)NC=O | InChi: | InChI=1S/C12H13N3O4/c13-8(12(18)19)3-6-4-14-10-7(6)1-2-9(11(10)17)15-5-16/h1-2,4-5,8,14,17H,3,13H2,(H,15,16)(H,18,19)/t8-/m0/s1 | Definition date: | 2006-08-22 | Last modified: | 2023-11-03 | Identifier: | 6-(formylamino)-7-hydroxy-L-tryptophan |
|
![1TY 1TY](https://data.pdbj.org/pdbjplus/data/cc/svg/1TY.svg) | 1TY | Name: | 3-{(3E)-4-HYDROXY-6-OXO-3-[(2-PHENYLETHYL)IMINO]CYCLOHEXA-1,4-DIEN-1-YL}ALANINE | Formula: | C17 H18 N2 O4 | SMILES: | O=C2C=C(O)/C(=N/CCc1ccccc1)C=C2CC(C(=O)O)N | InChi: | InChI=1S/C17H18N2O4/c18-13(17(22)23)8-12-9-14(16(21)10-15(12)20)19-7-6-11-4-2-1-3-5-11/h1-5,9-10,13,21H,6-8,18H2,(H,22,23)/b19-14+/t13-/m0/s1 | Definition date: | 2005-07-07 | Last modified: | 2023-11-03 | Identifier: | 3-{(3E)-4-hydroxy-6-oxo-3-[(2-phenylethyl)imino]cyclohexa-1,4-dien-1-yl}-L-alanine |
|
![1U8 1U8](https://data.pdbj.org/pdbjplus/data/cc/svg/1U8.svg) | 1U8 | Name: | (3S)-3-amino-5-[(2,6-dimethylbenzoyl)oxy]-4-oxopentanoic acid | Formula: | C14 H17 N O5 | SMILES: | O=C(O)CC(N)C(=O)COC(=O)c1c(cccc1C)C | InChi: | InChI=1S/C14H17NO5/c1-8-4-3-5-9(2)13(8)14(19)20-7-11(16)10(15)6-12(17)18/h3-5,10H,6-7,15H2,1-2H3,(H,17,18)/t10-/m0/s1 | Definition date: | 2013-03-28 | Last modified: | 2023-11-03 | Release date: | 2013-06-12 | Identifier: | (3S)-3-amino-5-[(2,6-dimethylbenzoyl)oxy]-4-oxopentanoic acid |
|
![LWI LWI](https://data.pdbj.org/pdbjplus/data/cc/svg/LWI.svg) | LWI | Name: | 2-(aminomethyl)-L-phenylalanine | Formula: | C10 H14 N2 O2 | SMILES: | NC(Cc1ccccc1CN)C(O)=O | InChi: | InChI=1S/C10H14N2O2/c11-6-8-4-2-1-3-7(8)5-9(12)10(13)14/h1-4,9H,5-6,11-12H2,(H,13,14)/t9-/m0/s1 | Definition date: | 2020-06-09 | Last modified: | 2023-11-03 | Release date: | 2021-03-31 | Identifier: | 2-(aminomethyl)-L-phenylalanine |
|
![LWO LWO](https://data.pdbj.org/pdbjplus/data/cc/svg/LWO.svg) | LWO | Name: | 2-(1H-benzotriazol-1-yl)-N-[4-(methylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide | Formula: | C20 H19 N5 O S | SMILES: | O=C(Cn1nnc2ccccc21)N(Cc1ccsc1)c1ccc(NC)cc1 | InChi: | InChI=1S/C20H19N5OS/c1-21-16-6-8-17(9-7-16)24(12-15-10-11-27-14-15)20(26)13-25-19-5-3-2-4-18(19)22-23-25/h2-11,14,21H,12-13H2,1H3 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(1H-benzotriazol-1-yl)-N-[4-(methylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide |
|
![LXF LXF](https://data.pdbj.org/pdbjplus/data/cc/svg/LXF.svg) | LXF | Name: | N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide | Formula: | C17 H17 N3 O3 S2 | SMILES: | O=S(=O)(NCCc1ccccc1)c1cccc2sc(nc12)NC(C)=O | InChi: | InChI=1S/C17H17N3O3S2/c1-12(21)19-17-20-16-14(24-17)8-5-9-15(16)25(22,23)18-11-10-13-6-3-2-4-7-13/h2-9,18H,10-11H2,1H3,(H,19,20,21) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide |
|
![1WI 1WI](https://data.pdbj.org/pdbjplus/data/cc/svg/1WI.svg) | 1WI | Name: | 1-[[4-fluoranyl-3-(3-oxidanylidene-4-pentan-3-yl-piperazin-1-yl)carbonyl-phenyl]methyl]quinazoline-2,4-dione | Formula: | C25 H27 F N4 O4 | SMILES: | CCC(CC)N1CCN(CC1=O)C(=O)c2cc(CN3C(=O)NC(=O)c4ccccc34)ccc2F | InChi: | InChI=1S/C25H27FN4O4/c1-3-17(4-2)29-12-11-28(15-22(29)31)24(33)19-13-16(9-10-20(19)26)14-30-21-8-6-5-7-18(21)23(32)27-25(30)34/h5-10,13,17H,3-4,11-12,14-15H2,1-2H3,(H,27,32,34) | Definition date: | 2022-11-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-[[4-fluoranyl-3-(3-oxidanylidene-4-pentan-3-yl-piperazin-1-yl)carbonyl-phenyl]methyl]quinazoline-2,4-dione |
|